Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 on the page; no evident changes to study details or related information.SummaryDifference0.1%

- Check25 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3; no changes to study content are visible.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 released, replacing v3.4.1.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page history now shows Revision: v3.4.1 replacing v3.4.0, indicating a minor update to the study details page.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study page now includes a 'Show glossary' option and new metadata fields: 'Last Update Submitted that Met QC Criteria' and the revision label 'v3.4.0'. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data' and revision 'v3.3.4' have been removed.SummaryDifference0.2%

- Check83 days agoChange DetectedPatch note updated to Revision: v3.3.4; the previous Revision: v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.